17th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target List csv
Targets are released at 9:30 am Pacific time (PDT=GMT-7hours) and expire at 9:00 am PDT.

Predictions in special categories, where a large number of models is requested, should be submitted before the Soft Deadline (typically 2 days before the Human Expiration) as submissions in these categories will not be checked immediately upon acceptance, but shortly afterwards. If model(s) have formatting issues, you will get a message from us within a few hours after the Soft Deadline so that you will have a chance to resubmit models before the Human Expiration deadline.

Green color - active target; Yellow color - target expires within 48 hours; Orange color - target expires within 24 hours
Nucleic acid-containing complexes are highlighted with the light grey background.

Target type 'h' is for human targets, 's' for server-only targets.
Target naming convention: Txxxx - protein monomers/homomers; Hxxxx - protein heteromers; Rxxxx - RNA monomers/homomers; Dxxxx - DNA monomers/homomers; Mxxxx (hybrid) - nucleic acid-containing hetero-complexes (with or without protein); Lxxxx - ligand only targets.
Stoichiometry 'UNK' stands for UNKNOWN.
* CAPRI target

All targets Mono/Homo -mers Multimers RNA Ligand Ensemble
Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all
#
Tar-id
Type
Res
Stoichiom.
Entry    
Date
Server
Expiration
Soft
Deadline
Human
Expiration
QA
Prediction
Description
1. L01 h Ligand 364 A1 2026-07-07 2026-07-14 2026-07-28 2026-08-28 - BFT1
2. L02 h Ligand 271 A1 2026-07-07 2026-07-14 2026-07-28 2026-08-27 - MmaA1
3. H1444 h Prot 588 UNK 2026-07-17 2026-07-20 2026-07-29 2026-07-31 - Fab-Ag-28368
4. H1441 h Prot 377 UNK 2026-07-17 2026-07-20 2026-07-29 2026-07-31 - NDM-1(ID C7C422) : Nanobody17
5. M1435 h Hybrid 622 UNK 2026-07-16 2026-07-19 2026-07-28 2026-07-30 - METTL16 (Uniprot: Q86W50)/MALAT1
6. T1440 h Prot 281 UNK 2026-07-15 2026-07-18 2026-07-27 2026-07-29 - Transcriptional regulator HilD
7. H1443 h Prot 586 UNK 2026-07-15 2026-07-18 2026-07-27 2026-07-29 - Fab-Ag-28367
8. H1442 h Prot 589 UNK 2026-07-14 2026-07-17 2026-07-26 2026-07-28 - Fab-Ag-28355
9. H1438 h Prot 755 UNK 2026-07-14 2026-07-17 2026-07-26 2026-07-28 - CP-H5 complex
10. T1430 h Prot 36 UNK 2026-07-13 2026-07-16 2026-07-25 2026-07-27 - TriPep
11. M1439 h Hybrid 649 UNK 2026-07-13 2026-07-16 2026-07-25 2026-07-27 - Intron-protein complex
12. W2386 h /Ensmbl 417 A1 2026-06-12 2026-06-19 2026-07-24 2026-07-26 - Group IIC Intron
13. W2385 h /Ensmbl 417 A1 2026-06-12 2026-06-19 2026-07-24 2026-07-26 - Group IIC Intron
14. R2415s0 h NucA 1231 A1 2026-07-03 2026-07-07 2026-07-23 2026-07-25 - U1 snRNP with ligand
15. M2415 h Prot-NucA/Ligand 1231 A1B1C1D1E1F1G1H1I1J1K1L1 2026-07-03 2026-07-07 2026-07-23 2026-07-25 from: 2026-07-25
to: 2026-07-28
U1 snRNP with ligand
16. T2406 * h Prot 479 A2 2026-07-10 2026-07-13 2026-07-22 2026-07-24 from: 2026-07-24
to: 2026-07-27
C0V70_15230
17. H1424 h Prot 2364 UNK 2026-07-10 2026-07-13 2026-07-24 2026-07-24 - 9NA bacteriophage baseplate
18. T2404 h Prot 263 A17 2026-07-09 2026-07-12 2026-07-21 2026-07-23 from: 2026-07-23
to: 2026-07-26
Cap19
19. E2376 h Prot /Ensmbl 662 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B42A
20. E2375 h Prot /Ensmbl 668 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B37B
21. T1421 h Prot 178 UNK 2026-07-08 2026-07-11 2026-07-20 2026-07-22 - YP_007379091.1
22. T1420 h Prot 92 UNK 2026-07-08 2026-07-11 2026-07-20 2026-07-22 - target13
23. H2403 * h Prot 568 A1B1C1 2026-07-08 2026-07-11 2026-07-20 2026-07-22 from: 2026-07-22
to: 2026-07-25
LujoGP+Fab14
24. H2402 * h Prot 579 A1B1C1 2026-07-08 2026-07-11 2026-07-20 2026-07-22 from: 2026-07-22
to: 2026-07-25
LujoGP+Fab13
25. T1418 h Prot 249 UNK 2026-07-07 2026-07-10 2026-07-19 2026-07-21 - CS201
26. H2401 * h Prot 572 A1B1C1 2026-07-07 2026-07-10 2026-07-19 2026-07-21 from: 2026-07-21
to: 2026-07-24
LujoGP+Fab12
27. H2400 * h Prot 572 A1B1C1 2026-07-07 2026-07-10 2026-07-19 2026-07-21 from: 2026-07-21
to: 2026-07-24
LujoGP+Fab11
28. H1419 h Prot 654 UNK 2026-07-07 2026-07-10 2026-07-19 2026-07-21 - SARS-CoV-2 spike (P0DTC2) RBD in complex with mAb
29. T2414 h Prot /Ligand 324 A1 2026-07-02 2026-07-05 2026-07-18 2026-07-20 - KIT kinase with inhibitor
30. T2413 h Prot /Ligand 274 A1 2026-07-02 2026-07-05 2026-07-18 2026-07-20 - PIM kinase with inhibitor
31. T1417 h Prot 249 UNK 2026-07-06 2026-07-09 2026-07-18 2026-07-20 - APR53_05355
32. T1416 h Prot 414 UNK 2026-07-06 2026-07-09 2026-07-18 2026-07-20 - CotH
33. H2399 * h Prot 568 A1B1C1 2026-07-06 2026-07-09 2026-07-18 2026-07-20 from: 2026-07-20
to: 2026-07-23
LujoGP+Fab10
34. H2398 * h Prot 570 A1B1C1 2026-07-06 2026-07-09 2026-07-18 2026-07-20 from: 2026-07-20
to: 2026-07-23
LujoGP+Fab9
35. T2412 h Prot /Ligand 225 A1 2026-07-01 2026-07-04 2026-07-17 2026-07-19 - SETDB1-ligand complex
36. T2411 h Prot /Ligand 472 A1 2026-07-01 2026-07-04 2026-07-17 2026-07-19 - Amidase with U08
37. T2410 h Prot /Ligand 472 A1 2026-06-30 2026-07-03 2026-07-16 2026-07-18 - Amidase with CID 343975
38. T2409 h Prot /Ligand 472 A1 2026-06-30 2026-07-03 2026-07-16 2026-07-18 - Amidase with UO4
39. E2369 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-D603G-Q617K
40. E2368 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-Q617K
41. H2423 s Server only 591 A2B2 2026-07-13 2026-07-16 2026-07-16 2026-07-16 - SlpA4del
42. H2422 s Server only 586 A2B2 2026-07-13 2026-07-16 2026-07-16 2026-07-16 - SlpA
43. H2394 * h Prot 566 A3B3C3 2026-07-02 2026-07-05 2026-07-16 2026-07-16 from: 2026-07-16
to: 2026-07-19
LujoGP+Fab8
44. E2367 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-D603G
45. E2366 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-WT
46. T2393 * h Prot 576 A2 2026-07-01 2026-07-04 2026-07-15 2026-07-15 from: 2026-07-15
to: 2026-07-18
GLE_4604
47. H2392 * h Prot 707 A2B1C1 2026-07-01 2026-07-04 2026-07-15 2026-07-15 from: 2026-07-15
to: 2026-07-18
MeV H + Fab3
48. H2391 * h Prot 702 A3B3C3 2026-06-30 2026-07-03 2026-07-14 2026-07-14 from: 2026-07-14
to: 2026-07-17
MeV F + Fab4
49. H2389 * h Prot 702 A3B1C1 2026-06-30 2026-07-03 2026-07-14 2026-07-14 from: 2026-07-14
to: 2026-07-17
MeV F + Fab3
50. H2408 * h Prot 1138 A1B1C1 2026-06-29 2026-07-02 2026-07-11 2026-07-13 from: 2026-07-13
to: 2026-07-16
COQ3-COQ6-L2HGDH ternary complex
51. H2388 * h Prot 244 A1B1 2026-06-29 2026-07-02 2026-07-13 2026-07-13 from: 2026-07-13
to: 2026-07-16
14-3-3 gamma bound to LARP1 derived phosphopeptide
52. H1423 s Server only 591 UNK 2026-07-09 2026-07-13 2026-07-13 2026-07-13 - SlpA4del
53. H1422 s Server only 586 UNK 2026-07-09 2026-07-13 2026-07-13 2026-07-13 - SlpA
54. R2428 s NucA 87 A1 2026-07-09 2026-07-11 2026-07-11 2026-07-11 - BISPR RNA motif
55. T1407 h Prot 473 UNK 2026-06-26 2026-06-29 2026-07-08 2026-07-10 - P344_00610
56. T1406 h Prot 479 UNK 2026-06-26 2026-06-29 2026-07-08 2026-07-10 - C0V70_15230
57. R2427 s NucA 604 A1 2026-07-08 2026-07-10 2026-07-10 2026-07-10 - S.maI1 precat
58. H2382 * h Prot 700 A2B2C2 2026-06-26 2026-06-29 2026-07-10 2026-07-10 from: 2026-07-10
to: 2026-07-13
MeV H + Fab2
59. H2381 * h Prot 704 A3B3C3 2026-06-26 2026-06-29 2026-07-10 2026-07-10 from: 2026-07-10
to: 2026-07-13
MeV F + Fab2
60. T1405 h Prot 482 UNK 2026-06-25 2026-06-28 2026-07-07 2026-07-09 - PilK
61. T1404 h Prot 263 UNK 2026-06-25 2026-06-28 2026-07-07 2026-07-09 - Cap19
62. R2426 s NucA 851 A1B1 2026-07-07 2026-07-09 2026-07-09 2026-07-09 - B.cI4 postcat
63. H2380 * h Prot 693 A2B2C2 2026-06-25 2026-06-28 2026-07-09 2026-07-09 from: 2026-07-09
to: 2026-07-12
MeV H + Fab1
64. H2379 * h Prot 697 A3B3C3 2026-06-25 2026-06-28 2026-07-09 2026-07-09 from: 2026-07-09
to: 2026-07-12
MeV F + Fab1
65. R2425 s NucA 851 A1 2026-07-06 2026-07-08 2026-07-08 2026-07-08 - B.cI4 precat
66. R2377v2 h NucA /Ensmbl 276 A1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
67. R2377v1 h NucA /Ensmbl 276 A1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
68. M2377v2 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
69. M2377v1 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
70. H1403 h Prot 568 UNK 2026-06-24 2026-06-27 2026-07-06 2026-07-08 - LujoGP+Fab14
71. H1402 h Prot 579 UNK 2026-06-24 2026-06-27 2026-07-06 2026-07-08 - LujoGP+Fab13
72. H1401 h Prot 572 UNK 2026-06-23 2026-06-26 2026-07-05 2026-07-07 - LujoGP+Fab12
73. H1400 h Prot 572 UNK 2026-06-23 2026-06-26 2026-07-05 2026-07-07 - LujoGP+Fab11
74. H2374 * h Prot 739 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB13
75. H2373 * h Prot 725 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB194
76. H1399 h Prot 568 UNK 2026-06-22 2026-06-25 2026-07-04 2026-07-06 - LujoGP+Fab10
77. H1398 h Prot 570 UNK 2026-06-22 2026-06-25 2026-07-04 2026-07-06 - LujoGP+Fab9
78. T2371 * h Prot 151 A2 2026-06-19 2026-06-22 2026-07-03 2026-07-03 from: 2026-07-03
to: 2026-07-06
Q8TW57
79. T1397 s Server only 244 UNK 2026-06-19 2026-06-22 2026-07-01
canceled on
2026-06-27
2026-07-03
canceled on
2026-06-27
- Atlas virus capsid (Pao retrotransposon), GenBank:EPB78661
80. T1396 s Server only 239 UNK 2026-06-19 2026-06-22 2026-07-01
canceled on
2026-06-27
2026-07-03
canceled on
2026-06-27
- Atlas-Nbr capsid
81. T2395 h Prot 176 A5 2026-06-18 2026-06-21 2026-06-30 2026-07-02 from: 2026-07-02
to: 2026-07-05
Ab CSUA1 Fiber
82. H1394 h Prot 566 UNK 2026-06-18 2026-06-21 2026-06-30 2026-07-02 - LujoGP+Fab8
83. T1393 h Prot 576 UNK 2026-06-17 2026-06-20 2026-06-29 2026-07-01 - GLE_4604
84. R2390 h NucA/Ligand 34 A1 2026-06-17 2026-06-19 2026-06-29 2026-07-01 from: 2026-07-01
to: 2026-07-04
RNA-NMN complex
85. H1392 h Prot 707 UNK 2026-06-17 2026-06-20 2026-06-29 2026-07-01 - MeV H + Fab3
86. T2397 s Server only 244 A5 2026-06-27 2026-06-30 2026-06-30 2026-06-30 - Atlas virus capsid (Pao retrotransposon), GenBank:EPB78661
87. T2396 s Server only 239 A5 2026-06-27 2026-06-30 2026-06-30 2026-06-30 - Atlas-Nbr capsid
88. H1391 h Prot 702 UNK 2026-06-16 2026-06-19 2026-06-28 2026-06-30 - MeV F + Fab4
89. H1389 h Prot 702 UNK 2026-06-16 2026-06-19 2026-06-28 2026-06-30 - MeV F + Fab3
90. T2364 h Prot 86 A3 2026-06-15 2026-06-18 2026-06-29 2026-06-29 from: 2026-06-29
to: 2026-07-02
A0A178UXU6
91. R2387 h NucA/Ligand 43 A1 2026-06-15 2026-06-17 2026-06-27 2026-06-29 from: 2026-06-29
to: 2026-07-02
RNA-NAD+ complex
92. H1388 h Prot 244 UNK 2026-06-15 2026-06-18 2026-06-27 2026-06-29 - 14-3-3 gamma bound to LARP1 derived phosphopeptide
93. T2383 s Server /Ligand 1142 A1 2026-06-12 2026-06-15 2026-06-24 2026-06-26 - DNA damage-binding protein
94. H2362 * h Prot 1836 A1B1C1D1E1F1G1 2026-06-12 2026-06-15 2026-06-24 2026-06-26 from: 2026-06-26
to: 2026-06-29
HCMV with a FAB
95. H1382 h Prot 700 UNK 2026-06-12 2026-06-15 2026-06-24 2026-06-26 - MeV H + Fab2
96. H1381 h Prot 704 UNK 2026-06-12 2026-06-15 2026-06-24 2026-06-26 - MeV F + Fab2
97. H2360 * h Prot 1558 A1B1C1D1E1 2026-06-11 2026-06-14 2026-06-23 2026-06-25 from: 2026-06-25
to: 2026-06-28
P69905, P68871
98. H1380 h Prot 693 UNK 2026-06-11 2026-06-14 2026-06-23 2026-06-25 - MeV H + Fab1
99. H1379 h Prot 697 UNK 2026-06-11 2026-06-14 2026-06-23 2026-06-25 - MeV F + Fab1
100. T1378 h Prot 745 UNK 2026-06-10 2026-06-13 2026-06-22 2026-06-24 - GXZ23_02530
101. M1377 h Hybrid 462 UNK 2026-06-10 2026-06-13 2026-06-22 2026-06-24 - P15692-4 / 2XP
102. H2359 * h Prot 2336 A1B1C1D1E1F1 2026-06-10 2026-06-13 2026-06-22 2026-06-24 from: 2026-06-24
to: 2026-06-27
A0AB35JLN2, A0AAE5SBF7, A0A2S4JD57, A0A0Q0BBX2, A0A1A6E3L8, A0ABT2VBN8
103. H2356 h Prot 590 A8B4 2026-06-09 2026-06-12 2026-06-21 2026-06-23 from: 2026-06-23
to: 2026-06-26
A0A517IGU2, A0A517I5H8
104. H2355 * h Prot 708 A3B3C3 2026-06-08 2026-06-11 2026-06-20 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
105. H2354 * h Prot 726 A3B3C3 2026-06-08 2026-06-11 2026-06-22 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
106. H1374 h Prot 739 UNK 2026-06-08 2026-06-11 2026-06-20 2026-06-22 - HSV-2 gD - HAB13
107. H1373 h Prot 725 UNK 2026-06-08 2026-06-11 2026-06-20 2026-06-22 - HSV-2 gD - HAB194
108. T1372 h Prot 202 UNK 2026-06-05 2026-06-08 2026-06-19 2026-06-19 - Bd0552
109. T1371 h Prot 151 UNK 2026-06-05 2026-06-08 2026-06-19 2026-06-19 - Q8TW57
110. H2349 * h Prot 1030 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
111. H2348 * h Prot 1034 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
112. M1370 h Hybrid 274 UNK 2026-06-04 2026-06-07
canceled on
2026-06-05
2026-06-16
canceled on
2026-06-05
2026-06-18
canceled on
2026-06-05
- RVB14 Cloverleaf RNA and 3C protein complex
Canceled - structure from another group released.
113. H2347 * h Prot 876 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN15499 Fab-Fab complex
114. H2346 * h Prot 885 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN3753 Fab-Fab complex
115. H2344 * h Prot 734 A1B1C1 2026-06-03 2026-06-06 2026-06-17 2026-06-17 from: 2026-06-17
to: 2026-06-20
HSV gD - HAB72
116. T2342 * h Prot 1455 A3 2026-06-02 2026-06-05 2026-06-16 2026-06-16 from: 2026-06-16
to: 2026-06-19
Spike glycoprotein ectodomain
117. T1364 h Prot 86 UNK 2026-06-01 2026-06-04 2026-06-13 2026-06-15 - A0A178UXU6
118. R2365 h NucA/Ligand 60 A1 2026-06-01 2026-06-04 2026-06-13 2026-06-15 from: 2026-06-15
to: 2026-06-18
RNA-GTP complex
119. H2343 * h Prot 773 A1B1C1 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Hepatitis C Virus sE2 CBH-4G Fab complex
120. H2340 * h Prot 686 A3B3C3 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Parahenipavirus F protein /antibody complex
121. T2358 s Server only 151 A2 2026-06-10 2026-06-13 2026-06-13 2026-06-13 - A7XXF0_BP234
122. T1363 h Prot 170 UNK 2026-05-29 2026-06-01 2026-06-10 2026-06-12 - O36551
123. H1362 h Prot 1836 UNK 2026-05-29 2026-06-01 2026-06-10 2026-06-12 - HCMV with a FAB
124. T1361 h Prot 123 UNK 2026-05-28 2026-05-31 2026-06-09 2026-06-11 - ProteinMPNN mutated bromodomain of PF3D7_1033700 (PfBDP1-BRD); Q8IJ72
125. R2353 h NucA 394 A1 2026-05-28 2026-05-30 2026-06-09 2026-06-11 from: 2026-06-11
to: 2026-06-14
Tetrahymena Ribozyme Vc2 mutant RNA
126. H1360 h Prot 1558 UNK 2026-05-28 2026-05-31 2026-06-09 2026-06-11 - P69905, P68871
127. T1358 h Prot 151 UNK 2026-05-27 2026-05-30 2026-06-08 2026-06-10 - A7XXF0_BP234
128. R2352 h NucA 389 A1 2026-05-27 2026-05-29 2026-06-08 2026-06-10 from: 2026-06-10
to: 2026-06-13
Tetrahymena Ribozyme IC3 mutant RNA
129. H2335 * h Prot 1820 A1B1C1D1E1 2026-05-27 2026-05-30 2026-06-10 2026-06-10 from: 2026-06-10
to: 2026-06-13
HCMV Merlin gHgLgO-Fab complex
130. H1359 h Prot 2336 UNK 2026-05-27 2026-05-30 2026-06-08 2026-06-10 - A0AB35JLN2, A0AAE5SBF7, A0A2S4JD57, A0A0Q0BBX2, A0A1A6E3L8, A0ABT2VBN8
131. T1357 h Prot 196 UNK 2026-05-26 2026-05-29 2026-06-07 2026-06-09 - A7XX72_BP234
132. R2351 h NucA 389 A1 2026-05-26 2026-05-28 2026-06-07 2026-06-09 from: 2026-06-09
to: 2026-06-12
Tetrahymena Ribozyme R1 mutant RNA
133. H1356 h Prot 590 UNK 2026-05-26 2026-05-29 2026-06-07 2026-06-09 - A0A517IGU2, A0A517I5H8
134. R2350 h NucA 389 A1 2026-05-25 2026-05-27 2026-06-06 2026-06-08 from: 2026-06-08
to: 2026-06-11
Tetrahymena Ribozyme C7.2 mutant RNA
135. H1355 h Prot 708 UNK 2026-05-25 2026-05-28 2026-06-06 2026-06-08 - hemagglutinin/antibody
136. H1354 h Prot 726 UNK 2026-05-25 2026-05-28 2026-06-06 2026-06-08 - hemagglutinin/antibody
137. H1349 h Prot 1030 UNK 2026-05-22 2026-05-25 2026-06-03 2026-06-05 - gp130 antibody complex
138. H1348 h Prot 1034 UNK 2026-05-22 2026-05-25 2026-06-03 2026-06-05 - gp130 antibody complex
139. R2345 s NucA 64 A1 2026-05-21 2026-05-23 2026-06-04 2026-06-04 - R10C03
140. H1347 h Prot 876 UNK 2026-05-21 2026-05-24 2026-06-02 2026-06-04 - REGN15499 Fab-Fab complex
141. H1346 h Prot 885 UNK 2026-05-21 2026-05-24 2026-06-02 2026-06-04 - REGN3753 Fab-Fab complex
142. H2321 * h Prot 502 A2B2C2 2026-05-20 2026-05-23 2026-06-03 2026-06-03 from: 2026-06-03
to: 2026-06-06
Human astrovirus VA1 capsid spike - antibody 2A2 complex
PDB code 9oeg
143. H1344 h Prot 734 UNK 2026-05-20 2026-05-23 2026-06-03 2026-06-03 - HSV gD - HAB72
144. T1342 h Prot 1455 UNK 2026-05-19 2026-05-22 2026-06-02 2026-06-02 - Spike glycoprotein ectodomain
145. H2319 * h Prot 497 A2B2C2 2026-05-19 2026-05-22 2026-06-02 2026-06-02 from: 2026-06-02
to: 2026-06-05
Human astrovirus VA1 capsid spike - antibody 7C8 complex
PDB code 9oef
146. R2341 h NucA 186 A1 2026-05-18 2026-05-20 2026-06-01 2026-06-01 from: 2026-06-01
to: 2026-06-04
RRE core
147. H1343 h Prot 773 UNK 2026-05-18 2026-05-21 2026-06-01 2026-06-01 - Hepatitis C Virus sE2 CBH-4G Fab complex
148. H1340 h Prot 686 UNK 2026-05-18 2026-05-21 2026-06-01 2026-06-01 - Parahenipavirus F protein /antibody complex
149. H2339 * h Prot 1044 A1B1C1D1 2026-05-15 2026-05-18 2026-05-22 2026-05-30 from: 2026-05-30
to: 2026-06-02
Factor XIa antibody complex 7508
PDB code 9yrb
150. H2338 * h Prot 1050 A1B1C1D1 2026-05-14 2026-05-17 2026-05-21 2026-05-29 from: 2026-05-29
to: 2026-06-01
Factor XIa antibody complex 9933
PDB code 9yrq
151. T2313 * h Prot 618 A3 2026-05-14 2026-05-17 2026-05-28 2026-05-28 from: 2026-05-28
to: 2026-05-31
P66
152. H2312 * h Prot 1409 A1B1C1 2026-05-13 2026-05-16 2026-05-27 2026-05-27 from: 2026-05-27
to: 2026-05-30
EXT1-EXT2-2BAV4
153. H1335 h Prot 1820 UNK 2026-05-13 2026-05-16 2026-05-27 2026-05-27 - HCMV Merlin gHgLgO-Fab complex
154. T1331 h Prot 281 UNK 2026-05-12 2026-05-15 2026-05-26 2026-05-26 - 5AT
155. H1332 h Prot 704 UNK 2026-05-11 2026-05-14
canceled on
2026-05-18
2026-05-25
canceled on
2026-05-18
2026-05-25
canceled on
2026-05-18
- Fab 047-09_1A02 binding influenza virus H1 HA
Canceled - preprint.
156. R2337s0 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
157. R2336 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron precat
158. M2337 s Hybrid 644 A1B1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
159. H2324 * h Prot 856 A1B1C1D1E1 2026-05-07 2026-05-10 2026-05-21 2026-05-21 from: 2026-05-21
to: 2026-05-24
T Cell Receptor N17.2, complex (5 chains)
PDB code 9yw4
160. H1321 h Prot 502 UNK 2026-05-06 2026-05-09 2026-05-20 2026-05-20 - Human astrovirus VA1 capsid spike - antibody 2A2 complex
PDB code 9oeg
161. H1319 h Prot 497 UNK 2026-05-05 2026-05-08 2026-05-19 2026-05-19 - Human astrovirus VA1 capsid spike - antibody 7C8 complex
PDB code 9oef
162. R2334 s NucA /Ensmbl 609 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
163. M2334 s Hybrid 1204 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
164. R2333s0 s NucA /Ensmbl 614 A1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
165. M2333 s Hybrid 614 A1B1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
166. T1313 h Prot 618 UNK 2026-04-30 2026-05-03 2026-05-14 2026-05-14 - P66
167. R2330 s NucA/Ligand 75 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - TPP riboswitch holo
168. R2329 s NucA/Ligand 60 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - SAMURI ribozyme holo
169. R2323 s NucA /Ensmbl 83 A2 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 WT
170. R2322 s NucA /Ensmbl 83 A1 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 monomer mutant
171. R2328 s NucA/Ligand 32 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Isoleucine binding aptamer
172. R2327 s NucA/Ligand 40 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Histidine binding aptamer
173. R2326 s NucA/Ligand 37 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Arginine binding aptamer
174. H1312 h Prot 1409 UNK 2026-04-29 2026-05-02 2026-05-13 2026-05-13 - EXT1-EXT2-2BAV4
175. H1311 * h Prot 822 A1B1C1D1E1 2026-04-28 2026-05-02 2026-05-13 2026-05-13 from: 2026-05-13
to: 2026-05-16
NRAS17.3.2_Q61K_HLAA1
PDB code 9zcl
176. R2325 s NucA 499 A2 2026-05-08 2026-05-11 2026-05-11 2026-05-11 - O.i. group II intron dimer
177. R2320s0 s NucA 731 A1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
178. M2320 s Hybrid 731 A1B1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
179. R2318 s NucA/Ligand 140 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Dha Glycine riboswitch holo
180. R2317 s NucA/Ligand 129 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Lmo Glycine riboswitch holo
181. R2316 s NucA 97 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - miniTTR GNRA tetraloop/receptor
182. R2315 s NucA /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer apo
183. R2314 s NucA/Ligand /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer holo
184. R2310 s NucA /Ensmbl 788 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
185. R2309 s NucA /Ensmbl 810 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron precat
186. M2310 s Hybrid /Ensmbl 810 A1B1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
187. R2308 s NucA 93 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - Triphosphorylation ribozyme
188. R2307 s NucA 100 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - gRNAde design
PDB code 10zt
189. R2306 s NucA 100 A1 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-fixbb design
PDB code 10zu
190. R2305 s NucA 105 A2 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-RFdiff design
PDB code 11ag
191. R2304 s NucA 100 A1 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Struct2SeQ SHAPE design
PDB code 11eh
192. R2303 s NucA 84 A2 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Eterna ZG_113_EliFisker_F_10
193. R2302 s NucA 90 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna PK90_14 f39
194. R2301 s NucA 96 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna JR_UC2199_030
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2026, University of California, Davis
Terms of Use